Natural History Studies (NHS) are important in understanding the natural progression of a condition. This information can then be used to predict what may happen in the future when children are diagnosed with genetic epilepsies, and are essential when planning trials of treatment. We talk with Dr Katherine Howell, the principal investigator of the international SCN2A Natural History Study.

Hosted by Kris Pierce and David Cunnington, parents of Will, who has SCN2A.

Leave a review and subscribe via Apple Podcasts. 

You can also find SCN2A Insights on Spotify, and Google Podcasts or in your podcast app

Links: 
SCN2A Encephalopathy –   2015
Genetic and phenotypic heterogeneity in SCN2A – 2017 (Marcus Wolff)
Email to register interest in participating in natural history study

Natural History Studies (NHS) are important in understanding the natural progression of a condition. This information can then be used to predict what may happen in the future when children are diagnosed with genetic epilepsies, and are essential when planning trials of treatment. We talk with Dr Katherine Howell, the principal investigator of the international SCN2A Natural History Study.
Hosted by Kris Pierce and David Cunnington, parents of Will, who has SCN2A.
Leave a review and&nbsp;subscribe via&nbsp;<a href="https://podcasts.apple.com/au/podcast/scn2a-insights/id1479681243?mt=2&amp;app=podcast">Apple Podcasts</a>.&nbsp;
You can also find SCN2A Insights on&nbsp;<a href="https://open.spotify.com/show/6KrDEmN7XPh8oDR7zR48cy">Spotify</a>, and&nbsp;<a href="https://podcasts.google.com/?feed=aHR0cHM6Ly93d3cub21ueWNvbnRlbnQuY29tL2QvcGxheWxpc3QvMjNkMTM3YTEtNDQxNi00MGQ2LWE1ZmMtYTUyOTAwMDFlY2RkLzA5MmMwZGNhLWQ0OTgtNDlkYy1hY2RkLWFhNzgwMGI3YWIyZC9jZDc2ZmU4Ni05MTA3LTQxMzYtYmY4Mi1hYTc4MDBiODVmZWQvcG9kY2FzdC5yc3M%3D">Google Podcasts</a>&nbsp;or in your podcast app
Links:&nbsp;
<ul>
<li><a href="https://www.ncbi.nlm.nih.gov/pubmed/26291284">SCN2A Encephalopathy</a>&nbsp;&ndash; &nbsp; 2015</li>
<li><a href="https://www.ncbi.nlm.nih.gov/pubmed/28379373">Genetic and phenotypic heterogeneity in SCN2A</a>&nbsp;&ndash; 2017 (Marcus Wolff)</li>
<li><a href="mailto:scn2a@mcri.edu.au">Email to register interest in participating in natural history study</a></li>
</ul>

Listen to SCN2A Insights to keep up to date with the latest research in SCN2A, genetic epilepsy and rare genetic disorders. Hosted by Ms Kris Pierce, RARE Global Advocacy Leadership Council member, and Dr David Cunnington, parents of Will, who has SCN2A.

Listen to SCN2A Insights to keep up to date with the latest research in SCN2A, genetic epilepsy and rare genetic disorders. Hosted by Ms Kris Pierce, RARE Global Advocacy Leadership Council member, and Dr David Cunnington, parents of Will, who has SCN2A.

SCN2A Insights brings you the latest research and clinical information on SCN2A from experts around the world.

SCN2A Insights

Listen to SCN2A Insights to keep up to date with the latest research in SCN2A, genetic epilepsy and rare genetic disorders.

Hosted by Ms Kris Pierce, RARE Global Advocacy Leadership Council member, and Dr David Cunnington, parents of Will, who has SCN2A.

Listen to SCN2A Insights to keep up to date with the latest research in SCN2A, genetic epilepsy and rare genetic disorders.
Hosted by Ms Kris Pierce, RARE Global Advocacy Leadership Council member, and Dr David Cunnington, parents of Will, who has SCN2A.

Natural History Studies (NHS) are important in understanding the natural progression of a condition and are essential when planning trials of treatment.

Advertisement